about
On the road to eliminate malaria in Sri Lanka: lessons from history, challenges, gaps in knowledge and research needsUse of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparumIn vivo transcriptional profiling of Plasmodium falciparumApplication of genomics to field investigations of malaria by the international centers of excellence for malaria researchNovel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse ModelIn Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered GrowthDiversity-oriented synthesis yields novel multistage antimalarial inhibitorsA genomic and evolutionary approach reveals non-genetic drug resistance in malariaIdentification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparumModulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugsRDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros IslandsA systematic map of genetic variation in Plasmodium falciparumIdentification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparumInferring developmental stage composition from gene expression in human malariaAn adjustable gas-mixing device to increase feasibility of in vitro culture of Plasmodium falciparum parasites in the fieldDuplication, gene conversion, and genetic diversity in the species-specific acyl-CoA synthetase gene family of Plasmodium falciparumThe role of DNA mismatch repair in generating genetic diversity and drug resistance in malaria parasitesCOIL: a methodology for evaluating malarial complexity of infection using likelihood from single nucleotide polymorphism dataIn vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins.Drug-induced alterations in gene expression of the asexual blood forms of Plasmodium falciparum.High-throughput Plasmodium falciparum growth assay for malaria drug discovery.Pre-amplification methods for tracking low-grade Plasmodium falciparum populations during scaled-up interventions in Southern Zambia.High resolution melting: a useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic Plasmodium populations.Case report of Plasmodium ovale curtisi malaria in Sri Lanka: relevance for the maintenance of elimination status.A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials--increased sensitivity of P. falciparum to chloroquine in SenegalGeographic structure of Plasmodium vivax: microsatellite analysis of parasite populations from Sri Lanka, Myanmar, and Ethiopia.Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies.Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical PneumoniaNuclear repositioning precedes promoter accessibility and is linked to the switching frequency of a Plasmodium falciparum invasion geneAminoindoles, a novel scaffold with potent activity against Plasmodium falciparum.A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.Low-complexity regions in Plasmodium falciparum: missing links in the evolution of an extreme genome.Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae.Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria.Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.Transcriptional profiling of Plasmodium falciparum parasites from patients with severe malaria identifies distinct low vs. high parasitemic clusters.Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agentsThe paradoxical population genetics of Plasmodium falciparum.
P50
Q21245929-08555D70-71C0-4E88-A59D-5B896C4C467CQ24653974-779DFFBC-5774-43DD-8901-ADAC27A2E747Q24802139-4AFC2D59-2E24-429D-885F-F423A88BA69DQ27010267-064FAA80-068D-4E70-B1F7-7CE50F8229DBQ27664030-E73F053E-47A6-4409-987E-9AD5EE119B13Q27683596-397EBF32-EE44-4244-A8FB-E2D97D68B31BQ27861934-6CE0BC41-4203-4640-88EA-6290FB4AFA93Q27861944-2BDC4C0E-DAAF-490D-8DED-40AA46615290Q27972613-96AF7D73-58CF-4DC0-A443-36370AFE2AABQ27974553-C26EB52B-E3DF-42A6-8A4A-0C7002CF916BQ28125925-6C7814B0-E770-47FA-AABF-9FD79A4EDD57Q28469012-63961CE5-962A-4489-B552-A07172C4964AQ28477846-0F9D01B6-3C70-447A-9B76-8FF12BD502E5Q28536897-700AEDCC-5620-4EFE-9459-F5021561DAC1Q28540589-2494CDBE-A15D-4762-BD61-A9F463B590CBQ30041511-5BAC08C0-C167-434A-A20E-25F5FCB4350BQ30043983-F0992DBE-E794-420A-B03C-ACF7DD3199D3Q30884940-0EE333AD-674C-4396-9B98-AD5B6F253299Q30984141-FA9CDE8E-CFA5-4F1B-AD97-DC9275C1691CQ31026578-F15FA0B1-6DA9-49B9-96F5-36EF50C7FC28Q33264146-5FA92636-C35F-453E-A039-51A255C93D90Q33556831-1513ACC5-6CA8-4E02-9742-3289826C16B6Q33576274-8F49AD3D-DF9A-44F2-970B-05A2F56819FFQ33602130-6198FBB7-6104-40A5-BA83-7BC2E7074E5FQ33617554-B14C6060-6DFF-4AA0-AC50-CBAA77777C49Q33617568-6A039D35-14CE-4189-9FAD-D89A055900B7Q33631643-FCA9812B-5BE8-40F3-AC7E-7861041FB237Q33668137-F31501B1-1339-4512-94F8-C4BD62552BFCQ33714041-E40C173B-9D21-42B2-85FA-F86B71CC4508Q33791381-4ECB24BC-40E7-448A-A66A-FD777834D4ECQ33851108-0C50D7A8-BDF6-4F01-8BB6-AF236244516BQ33920004-27A69EE1-2B94-4226-B8E6-5B02586BF95BQ34034163-E3AF6990-C9F3-45D6-A7EB-5EBA9260E1C8Q34069896-3414F83F-1066-44DD-B113-F885E05A9150Q34113689-997AE958-EA5E-4F3F-80D9-00FAC5006268Q34157359-71D57C87-7976-4509-B735-3759ADC44C03Q34253805-14F873C4-39B3-4383-9CFF-58CCE6642924Q34345090-27587177-0CB9-443F-A85F-B4B6995823ADQ34394236-2F6D9263-F1E1-4C52-BB4C-B4F8908C159CQ34660994-26917D67-770E-4A77-9FE0-C04B4B064F6C
P50
description
American immunologist
@en
hulumtuese
@sq
immunoloog
@nl
հետազոտող
@hy
name
Dyann Wirth
@ast
Dyann Wirth
@en
Dyann Wirth
@es
Dyann Wirth
@nl
type
label
Dyann Wirth
@ast
Dyann Wirth
@en
Dyann Wirth
@es
Dyann Wirth
@nl
altLabel
D F Wirth
@en
D Wirth
@en
D. F Wirth
@en
D. Wirth
@en
Dyann F Wirth
@en
Dyann F. Wirth
@en
Dyann Lynn Fergus
@en
Wirth D
@en
Wirth D. F.
@en
Wirth D.
@en
prefLabel
Dyann Wirth
@ast
Dyann Wirth
@en
Dyann Wirth
@es
Dyann Wirth
@nl
P101
P106
P21
P2381
P31
P3388
P496
0000-0002-8604-4455
P569
1951-01-31T00:00:00Z